PRIA Logo™
119-s-5079119th Congress

AG2PI Act of 2026

Sponsored By: Senator McCormick, David [R-PA]

Introduced

Summary

This bill would extend the Genome to Phenome Initiative's authorization through 2031, moving the statutory end year forward to continue the program. It also sets the short title as the Genome to Phenome Initiative Reauthorization Act of 2026, also called the AG2PI Act of 2026.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Extend genome research program authorization

If enacted, this bill would extend the Genome to Phenome Initiative's authorization through the year 2031 by changing the date in existing law. The change would take effect upon enactment. It would not itself provide new funding or change who can get grants. Researchers and research institutions tied to the program would remain authorized to operate under it.

Sponsors & CoSponsors

Sponsor

McCormick, David [R-PA]

PA • R

Cosponsors

  • Sen. Hickenlooper, John W. [D-CO]

    CO • D

    Sponsored 7/22/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation